Your session is about to expire
← Back to Search
Telemonitoring Program for Abdominal Cancers
Study Summary
This trial compares a home-based telemonitoring program to surgeon only care in improving recovery and stopping complications after surgery.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am scheduled for major surgery for cancer in my abdomen.I can read and understand either English or Spanish.My condition is at any stage of the disease.
- Group 1: Group I (telemonitoring program, actigraph, TapCloud)
- Group 2: Group II (surgeon-only perioperative care program)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any opportunities for participants in this trial at present?
"Affirmative. According to clinicaltrials.gov, this medical study is presently actively recruiting individuals for participation. It was initially posted on February 16th 2021 and was most recently updated on July 6th 2022 - with a total of 332 participants needed from 3 distinct sites."
What would be the anticipated results of this examination?
"This clinical trial's primary aim is to determine the maximum Clinical Condition Index (CCI) over a period of 30 days following surgery. Secondary objectives include monitoring changes in overall symptoms through MD Anderson Symptom Inventory, sedentary time via Actigraph GT9X Link and disease-specific indicators with MD Anderson Symptom Library Items. The data collected will focus on two metrics: number of steps taken daily and sedentary time which can be categorised into low (<100 cpm), moderate/vigorous (>1952 cpm) levels using recommended activity counts per minute cutpoints."
Share this study with friends
Copy Link
Messenger